Literature DB >> 31314741

Reply to comments on "State of the art in magnetic resonance imaging of hepatocellular carcinoma": the role of DWI.

Natally Horvat1,2,3, Serena Monti4, Brunna Clemente Oliveira2,3, Camila Carlos Tavares Rocha3, Romina Grazia Giancipoli5, Lorenzo Mannelli1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31314741      PMCID: PMC6765157          DOI: 10.2478/raon-2019-0030

Source DB:  PubMed          Journal:  Radiol Oncol        ISSN: 1318-2099            Impact factor:   2.991


× No keyword cloud information.

Author’s reply

We were very pleased to read the comments from Dr Granata and colleagues in Radiology and Oncology about our article “State of the art in magnetic resonance imaging of hepatocellular carcinoma”.1 As highlighted, the diffusion weighted imaging (DWI) plays a key role as a qualitative and quantitative method in the detection of hepatocellular carcinoma (HCC), mostly for small (< 20 mm) or well-differentiated HCC with atypical post-contrast imaging patterns2, helping differentiate benign from malignant focal hepatic lesions, and also allowing the evaluation of treatment response to systemic and locoregional therapies in hepatic malignancies. DWI is an MRI sequence which provides useful information especially in the absence of intravenous contrast media.3 In this context, the intravoxel incoherent motion (IVIM) model is based on the fact that perfusion exists inherently in DWI voxels and influences the measurement of the apparent diffusion coefficient (ADC), allowing qualitative and quantitative assessment. It can be used in the differentiation between benign and malignant hepatic nodule, such as focal nodular hyperplasia and HCC.4 Furthermore, a few recent studies showed that there is a correlation between the histopathological grade and prognosis of HCC and DWI, demonstrating that significantly lower ADC values in poorly differentiated tumors with a shorter recurrence-free survival and a cut-off value of 1.175 x 10-3 mm2/s to predict microvascular invasion.5, 6 Regarding Diffusion kurtosis imaging (DKI), we also recognize its current role in the evaluation of non-Gaussian water diffusion, providing better information in heterogeneous tissues such as large HCCs, even in the post-treatment studies. Wang et al. suggested that a mean Kurtosis value cut-off of 0.917 has a good sensitivity, specificity and diagnostic accuracy in the prediction of microvascular invasion, as the ADC value commented above.7 However, to our knowledge there is not enough evidence to correlate the quantitative parameters obtained with DWI and IVIM with HCC physiopathology or pathologic subtypes. This is possibly due to the discrepancy in the current spatial resolution of DWI/IVIM and pathologic findings, the currently described correlations are significant but underline a gap of knowledge between what is observed at MRI and what is observed at pathology. The hope is that IVIM may be able to describe subcategories of HCCs of among the pathologic descriptors allowing for better treatment tailoring and prognostic assessment. Finally, it is important to emphasize that all the information obtained from DWI is complementary and does not replace the use of intravenous contrast agents, Hectors et al. proved that these sequences offer non-redundant data on flow and perfusion inside the tumor, probably due to the change in the microvascular supply, although they presented moderate to strong correlation in the surrounding liver.8
  8 in total

1.  Intravoxel incoherent motion diffusion-weighted imaging of hepatocellular carcinoma: Is there a correlation with flow and perfusion metrics obtained with dynamic contrast-enhanced MRI?

Authors:  Stefanie J Hectors; Mathilde Wagner; Cecilia Besa; Octavia Bane; Hadrien A Dyvorne; M Isabel Fiel; Hongfa Zhu; Michael Donovan; Bachir Taouli
Journal:  J Magn Reson Imaging       Date:  2016-02-26       Impact factor: 4.813

2.  Diffusion-weighted magnetic resonance imaging predicts malignant potential in small hepatocellular carcinoma.

Authors:  Shusuke Okamura; Shuji Sumie; Tatsuyuki Tonan; Masahito Nakano; Manabu Satani; Shigeo Shimose; Tomotake Shirono; Hideki Iwamoto; Hajime Aino; Takashi Niizeki; Nobuyoshi Tajiri; Ryoko Kuromatsu; Koji Okuda; Osamu Nakashima; Takuji Torimura
Journal:  Dig Liver Dis       Date:  2016-06-01       Impact factor: 4.088

3.  Intravoxel incoherent motion: application in differentiation of hepatocellular carcinoma and focal nodular hyperplasia.

Authors:  Ma Luo; Ling Zhang; Xin Hua Jiang; Wei Dong Zhang
Journal:  Diagn Interv Radiol       Date:  2017 Jul-Aug       Impact factor: 2.630

4.  Early hepatocellular carcinoma that develops within macroregenerative nodules: growth rate depicted at serial MR imaging.

Authors:  A G Sadek; D G Mitchell; E S Siegelman; E K Outwater; T Matteuccí; H W Hann
Journal:  Radiology       Date:  1995-06       Impact factor: 11.105

5.  Assessment of Microvascular Invasion of Hepatocellular Carcinoma with Diffusion Kurtosis Imaging.

Authors:  Wen-Tao Wang; Li Yang; Zhao-Xia Yang; Xin-Xing Hu; Ying Ding; Xu Yan; Cai-Xia Fu; Robert Grimm; Meng-Su Zeng; Sheng-Xiang Rao
Journal:  Radiology       Date:  2017-09-22       Impact factor: 11.105

Review 6.  State of the art in magnetic resonance imaging of hepatocellular carcinoma.

Authors:  Natally Horvat; Serena Monti; Brunna Clemente Oliveira; Camila Carlos Tavares Rocha; Romina Grazia Giancipoli; Lorenzo Mannelli
Journal:  Radiol Oncol       Date:  2018-11-26       Impact factor: 2.991

Review 7.  The current role and future prospectives of functional parameters by diffusion weighted imaging in the assessment of histologic grade of HCC.

Authors:  Vincenza Granata; Roberta Fusco; Salvatore Filice; Orlando Catalano; Mauro Piccirillo; Raffaele Palaia; Francesco Izzo; Antonella Petrillo
Journal:  Infect Agent Cancer       Date:  2018-07-03       Impact factor: 2.965

Review 8.  Diffusion weighted magnetic resonance imaging of liver: Principles, clinical applications and recent updates.

Authors:  Anuradha Shenoy-Bhangle; Vinit Baliyan; Hamed Kordbacheh; Alexander R Guimaraes; Avinash Kambadakone
Journal:  World J Hepatol       Date:  2017-09-18
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.